Monday, 1 Sept
46
ECP 2014 ·
London
Scientific Programme
a
Monday
009
15:50 – 16:00
miRNAs detection in stool accurately identi-
fies colorectal cancer patients for population
screening purposes
Beatriz Carvalho,
The Netherlands
L. M. Timmer, M. A. van de Wiel, A. S.
Bolijn, L. Bosch, C. J. J. Mulder,
R. Q. J. Schaapveld, E. Berezikov, E. Cuppen,
G. A. Meijer, B. Diosdado
010
16:00 – 16:10
Evaluating the performance of clinicopatho-
logical criteria to predict CDH1 mutations in
hereditary diffuse gastric cancer
Chella van der Post,
The Netherlands
P. Manders, I. Vogelaar, J. Wes, L. van der Kolk,
A. Cats, O. Balague Ponz, A. Mensenkamp,
N. Hoogerbrugge, M. Ligtenberg, H. van Krieken
011
16:10 – 16:20
Bone marrow-derived mesenchymal cells as a
treatment for experimental liver fibrosis in rats
Iman Shaheed,
Egypt
F. Ahmed, N. Ramdan
OFP-09
Oral Free Paper Session
14:30 – 16:30
ICC Capital Suite 1
Endocrine and Molecular Breast Pathology
Chairs:
Stefano La Rosa,
Italy
Yersu Kapran,
Turkey
001
14:30 – 14:40
The grey zone between small cell carcinoma
and Ewing family tumour of the thyroid
Catarina Eloy,
Portugal
S. Sapia, M. Sobrinho Simões
002
14:40 – 14:50
SF3B1 K700E mutations are associated with
alternative splicing in oestrogen receptor-
positive breast cancer
Sarah Maguire,
United Kingdom
A. Leonidou, P. Wai, C. Marchiò,
C. Ng, B. Weigelt, A. Sapino, A. Vincent-
Solomon, J. Reis-Filho, R. Natrajan
003
14:50 – 15:00
Proteomics of breast cancer
Ola Negm,
United Kingdom
D. Jerjees, A. Alshareeda, A. Green, V. Band,
S. Mirza, P. Tighe, I. Ellis, E. Rakha
004
15:00 – 15:10
Unlocking the pathological achieves: High-
throughput proteomic study for FFPE tissue
using RPPA
Ola Negm,
United Kingdom
A. Muftah, A. Green, C. Nolan, P. Tighe,
I. Ellis, E. Rakha
005
15:10 – 15:20
Immunohistochemical expression of soma-
tostatin receptor subtypes 2 and 5 in Merkel
cell carcinoma: Preliminary data
Vera Delektorskaya,
Russia
K. Orlova, L. Demidov
006
15:20 – 15:30
Utility of emerin Immunohistochemistry
(IHC) in well differentiated epithelial lesions
of thyroid
Ipek Coban,
Turkey
G. Bulbul Dogusoy, A. Erdogan Cakir,
T. D. Kokenek Unal, E. Karakilic, M. Alper
007
15:30 – 15:40
Clinical significance of cannabinoid recep-
tors CB1 and CB2 expression in human ma-
lignant and benign thyroid lesions
Eleftheria Lakiotaki,
Greece
C. Giaginis, P. Alexandrou, I. Delladetsima,
I. Giannopoulou, E. Patsouris, S. Theocharis
008
15:40 – 15:50
Clinical significance of EphB4 and EphB6
expression in human malignant and benign
thyroid lesions
Constantinos Giaginis,
Greece
P. Alexandrou, I. Delladetsima, C. Troungos,
E. Patsouris, S. Theocharis
009
15:50 – 16:00
Variation in the protein phosphatase 2A
(PP2A) complex is a common event in breast
cancer patients
Shawn Baldacchino,
Malta
C. Saliba, S. Falzon, K. Sacco, J. De Gaetano,
G. Caruana Dingli, J. Debono, A. G. Fenech,
C. Scerri, G. Grech
010
16:00 – 16:10
Interlaboratory variability of MIB1 staining
in well differentiated pancreatic neuroendo-
crine tumours
Annika Blank,
Switzerland
L. Wehweck, I. Marinoni, L. Boos, A. Schmitt,
A. Perren
